References
- Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52(2):148–59.
- Dima A, Jurcut C, Baicus C. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int. 2018;38(7):1169–78.
- Gunnarsson R, Hetlevik SO, Lilleby V, Molberg Ø. Mixed connective tissue disease. Best Pract Res Clin Rheumatol. 2016;30(1):95–111.
- Ortega-Hernandez OD, Shoenfeld Y. Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheumatol. 2012;26(1):61–72.
- Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M, et al. The diagnosis and classification of mixed connective tissue disease. J Autoimmun. 2014;48–49:46–9.
- Kasukawa R. Mixed connective tissue disease. Intern Med. 1999;38(5):386–93.
- Doria A, Ghirardello A, de Zambiasi P, Ruffatti A, Gambari PF. Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients. J Rheumatol 1992;19(2):259–64.
- Amigues JM, Cantagrel A, Abbal M, Mazieres B. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol 1996;23(12):2055–62.
- Alarcón GS. Unclassified or undifferentiated connective tissue disease. Baillieres Best Pract Res Clin Rheumatol. 2000;14(1):125–37.
- Cappelli S, Bellando Randone S, Martinović D, Tamas M-M, Pasalić K, Allanore Y, et al. “To be or not to be,” ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2012;41(4):589–98.
- Sharp GC, Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp GC, editor. Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division); 1987. p. 23–30
- Alarcón-Segovia D, Villarreal M, Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC, editor. Mixed connective tissue disease and anti-nuclear antibodies. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division); 1987. p. 33–40.
- Yokota S, Imagawa T, Katakura S, Itoh SI, Mitsuda T, Fujikawa S, et al. Mixed connective tissue disease in childhood: a nationwide retrospective study in Japan. Acta Paediatr Jpn. 1997;39(2):273–6.
- Perelas A, Arrossi AV, Highland KB. Pulmonary manifestations of systemic sclerosis and mixed connective tissue disease. Clin Chest Med. 2019;40(3):501–18.
- Gunnarsson R, Andreassen AK, Molberg O, Lexberg AS, Time K, Dhainaut ASS, et al. Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature. Rheumatology. 2013;52(7):1208–13.
- Kasukawa R, Nishimaki T, Takagi T, Miyawaki S, Yokohari R, Tsunematsu T. Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study. Clin Rheumatol. 1990;9(1):56–62.
- Hosoda Y, Suzuki Y, Takano M, Tojo T, Homma M. Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study. J Rheumatol 1987;14(4):826–30.